Case Report (n=7)
The presence of lactate dehydrogenase-6 (LD-6) may serve as a biochemical marker of serious hepatic circulatory disturbance in patients with severe congestive heart failure.
LD-6 detection may flag high short-term mortality in severe HF; hypothesis-generating for hepatic marker role, needs validation.
I confirmed the existence of an additional isozyme band of lactate dehydrogenase (LD) (EC 1.1.1.27) cathodic to LD-5 utilizing agarose gel isozyme electrophoresis in seven patients. Three of the patients died of circulatory failure within three weeks after the isozyme was identified. Four patients survived after successful therapy for heart failure. The under-lying clinical condition was arteriosclerotic cardiovascular disease causing congestive heart failure with passive congestion of the major viscera. I performed biochemical analysis on the isozyme and found that it was extremely heat stable, was not immunoglobulin bound, and contained only M, not H, subunits. It may represent a posttranslationally modified LD-5 or alcohol dehydrogenase.
No takes yet. Share an insight, caveat, or question.
Paul L. Wolf (1985) conducted a case report in Arteriosclerotic cardiovascular disease causing congestive heart failure with passive congestion of the major viscera (n=7). Lactate dehydrogenase-6 (LD-6) isozyme band was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: